Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride reduces Tourette syndrome symptoms, but results may be limited due to potential biases.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

Some people experience severe, long-lasting side effects from fluoroquinolone antibiotics, leading to the recommendation of limited use and increased awareness of these risks.

Finasteride may help reduce symptoms in male Tourette syndrome patients.

Behavioral dermatology treats skin problems by considering both emotional and physical factors.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Alopecia is linked to various health and mental conditions, impacts life quality, and needs medical attention beyond its cosmetic effects.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

A male with aromatase deficiency improved bone health with estradiol treatment.

The skin is a complex barrier that protects the body, regulates temperature, and helps with immune responses.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Microencapsulation helps protect and track therapeutic cells, showing promise for treating various diseases, but more work is needed to improve the technology.

Premature ovarian insufficiency (POI) can harm women's sexual health, and they may benefit from hormone therapy and counseling.

The document describes a woman with familial Parkinson's disease due to a genetic mutation, showing severe symptoms and poor response to treatment, and suggests finasteride may help reduce symptoms in Tourette syndrome.

5-alpha-reductase inhibitors may cause a low incidence of erectile dysfunction that decreases over time.

Better-designed, long-term studies are needed to optimize treatment for trichotillomania and trichophagia.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

The document concludes that lifestyle changes and medical treatments can significantly reduce symptoms of Hidradenitis Suppurativa, a chronic skin condition.

Menopausal women have higher androgen levels, which can cause symptoms like facial hair growth and low sexual desire.

A teenage girl with high androgen levels and PCOS developed a rare liver tumor, suggesting a possible link between high androgens and the tumor's growth.

Pregnancy reduces anxiety in rats, but finasteride reverses this effect.

Many skin patients also have mental health issues, and doctors should treat both together.

Testosterone treatment in transgender teens can worsen acne, requiring careful treatment due to mental health and medication side effects.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

The review highlights the need for more research on transgender dermatology, the role of dermatologists in gender affirmation, and the effects of hormone therapy on skin and hair.

The 2018 update to the ED care model added a new severity score and stressed a detailed evaluation of both physical and psychological aspects.